Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany

Berlin

0 studies enrolling now · 1 studies all time

What they study most

Pyoderma Gangrenosum

Studies at this site

• Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum — Stopped early